Twenty-six-week-old laying hens (90 Lohmann Classic Brown) received dietary treatments containing canola and linseed oil at 2% inclusion levels and a control diet for 21 days. The 2% dietary linseed oil, which had higher total polyunsaturated fatty acids (ΣPUFA) and linolenic fatty acid contents, resulted in higher liver malondialdehyde and wider villi than the control group. The 2% canola and linseed oil treatments recorded smaller reproductive organs relative to live weight than the control group. It was concluded that young layers might have an anatomical response to high levels of dietary PUFA, which might improve nutrient absorption and cause a biochemical response, resulting in potentially negative cytotoxic aldehydic lipid peroxidation products. ______________________________________________________________________________________
The important functions of L-carnitine are fostering the oxidation of long-chain fatty acids by mitochondria and stimulating protein-sparing action by increasing energy derived from lipids. The present study was conducted to investigate dietary effects of L-carnitine on egg production of breeder ostriches. Ninety black neck ostrich breeder birds (60 females and 30 males) were examined randomly (completely randomised design) within three treatments and five replicates for 7 months in breeding season. A basal diet was formulated and used for the control group (L1), while two levels of L-carnitine, 250 mg/kg and 500 mg/kg, were included in the basal diet for treatments L2 and L3, respectively. The egg production percentage, egg weight and defective eggshell percentage were measured. The supplementary diet with 500 mg/kg L-carnitine increased (P < 0.01) the egg production percentage. Means (±s.e.) of egg production percentage for L1, L2 and L3 were 9.68, 12.95 and 17.13% (±1.08), respectively. L-carnitine had no effect on the egg weight and the defective eggshell percentage. The results suggest that basal diet supplemented with 500 mg/kg L-carnitine can increase the egg production percentage of ostriches.
________________________________________________________________________________ AbstractThe objective was to determine the growth responses of Black Neck ostrich chicks to different dietary levels of L-carnitine in pre-starter diets. Thirty-two day-old ostrich chicks were randomly divided into four treatments with four replicates, each containing two chicks. All birds received the same basal diet supplemented with 0 (T0, control), 125 (T125), 250 (T250) or 600 (T600) mg L-carnitine per kg. Responses were monitored over three growth phases, 0 -15, 16 -30 and 31 -60 days, the total period being 60 days. T600 had the lowest live weight (LW) and live weight gain (LWG) over the 60-day treatment period. Live weight and LWG values of T125 and T250 did not differ from those of T0. T600 had the worst feed conversion ratio (FCR) during the different stages (0 -15, 16 -30 and 31 -60 days) and over the total 60-day period. Feed intake (FI) was reduced significantly in the T125 and T600 treatments compared to T0 and T250 treatments over the total period. The treatment, T125, showed the lowest FI and FCR responses over the total period, whereas there was no difference between T0 and T250. The results suggest that supplementing the pre-starter diet with 125 mg/kg of L-carnitine can improve the performance of ostrich chicks by decreasing the FCR. In contrast, the suppressive effect of a high inclusion level (T600) might indicate that ostrich chicks are sensitive to a high level of inclusion that could cause adverse effects.
________________________________________________________________________________
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.